Drug Discovery: Overview
Ligand Binding Sites
Patch Clamp
Conserved Binding Sites
Structure-Activity Relationships and Drug Design
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 19, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Bas Lamoree1, Roderick E Hubbard2,3
1York Structural Biology Laboratory (YSBL), Department of Chemistry, University of York, Heslington, York YO10 5DD, U.K.
Fragment-based drug discovery is a mature method for identifying drug leads against conventional targets and challenging protein-protein interactions. This approach yields compounds in clinical trials and medicines, and serves as a tool in chemical biology research.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: